Kellner Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-29,200
Closed -$1.36M – 30
2023
Q2
$1.36M Buy
+29,200
New +$1.01M 1.56% 18

Kellner Capital's DICE Position: Q3 2023 in Review

Kellner Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 29,200 shares — an estimated $1.36M sold.

Kellner Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.36M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Kellner Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Kellner Capital sold 29,200 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.36M.
  • Kellner Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Kellner Capital's DICE Therapeutics, Inc. Common Stock position peaked at $1.36M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Kellner Capital's 13F filing for Q3 2023, filed 13 Nov 2023.